• AlzeCure receives US patent for NeuroRestore ACD856

  • AlzeCure's Alzheimer’s project NeuroRestore ACD856 shows positive effect on brain activity in clinical trial

  • AlzeCure presents new data on the anti-inflammatory effects of its TrkA-NAM pain project at IASP 2022

AlzeCure Pharma

AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders


AlzeCure is developing disease modifying and symptomatic first in class treatments for Alzheimer’s disease and other conditions characterized by cognitive dysfunction

Alzheimer’s Disease

Alzheimer’s disease is a deadly disorder which lacks effective treatments. The need for novel treatments is therefore urgent.